National Institute of Neurological Disorders and Stroke | 131 Pt 7 : 1940—52 |
---|---|
: Mayo Foundation for Medical Education and Research; 2018 | de Kraker M, Kluin J, Renken N, Maat AP, Bogers AJ 2005 |
Scherer K, Bedlack RS, Simel DL.
5Myasthenia Gravis Foundation of America | "Treatment of myasthenia gravis by preventing acetylcholine receptor modulation" |
---|---|
: The McGraw-Hill Companies; 2018 | Barbara Woodward Lips Patient Education Center |
107 4 : 211—4, 220—2.
30Myasthenia gravis: A guide for patients | Myasthenia gravis and other diseases of the neuromuscular junction |
---|---|
Myasthenia Gravis Foundation of America | "Does this patient have myasthenia gravis? |
"Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis".
8